FitLife Brands Pre-Tax Profit Margin 2010-2025 | FTLF
FitLife Brands pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| FitLife Brands Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.06B | $0.01B | 18.75% |
| 2024-12-31 | $0.07B | $0.01B | 18.46% |
| 2024-09-30 | $0.06B | $0.01B | 17.46% |
| 2024-06-30 | $0.06B | $0.01B | 16.39% |
| 2024-03-31 | $0.06B | $0.01B | 16.95% |
| 2023-12-31 | $0.05B | $0.01B | 15.09% |
| 2023-09-30 | $0.05B | $0.01B | 15.56% |
| 2023-06-30 | $0.04B | $0.01B | 17.95% |
| 2023-03-31 | $0.03B | $0.01B | 18.75% |
| 2022-12-31 | $0.03B | $0.01B | 25.00% |
| 2022-09-30 | $0.03B | $0.01B | 26.67% |
| 2022-06-30 | $0.03B | $0.01B | 24.14% |
| 2022-03-31 | $0.03B | $0.01B | 24.14% |
| 2021-12-31 | $0.03B | $0.01B | 25.00% |
| 2021-09-30 | $0.03B | $0.01B | 22.22% |
| 2021-06-30 | $0.03B | $0.01B | 25.93% |
| 2021-03-31 | $0.02B | $0.01B | 22.73% |
| 2020-12-31 | $0.02B | $0.00B | 18.18% |
| 2020-09-30 | $0.02B | $0.00B | 15.79% |
| 2020-06-30 | $0.02B | $0.00B | 11.76% |
| 2020-03-31 | $0.02B | $0.00B | 15.79% |
| 2019-12-31 | $0.02B | $0.00B | 15.79% |
| 2019-09-30 | $0.02B | $0.00B | 15.00% |
| 2019-06-30 | $0.02B | $0.00B | 10.00% |
| 2019-03-31 | $0.02B | $0.00B | 5.26% |
| 2018-12-31 | $0.02B | 0 | 0.00% |
| 2018-09-30 | $0.02B | $-0.01B | -47.06% |
| 2018-06-30 | $0.02B | $-0.01B | -56.25% |
| 2018-03-31 | $0.02B | $-0.01B | -58.82% |
| 2017-12-31 | $0.02B | $-0.01B | -55.56% |
| 2017-09-30 | $0.02B | $0.00B | -16.67% |
| 2017-06-30 | $0.02B | $0.00B | -10.53% |
| 2017-03-31 | $0.02B | 0 | 0.00% |
| 2016-12-31 | $0.03B | $0.00B | 4.00% |
| 2016-09-30 | $0.03B | 0 | 0.00% |
| 2016-06-30 | $0.03B | 0 | 0.00% |
| 2016-03-31 | $0.02B | $0.00B | -4.55% |
| 2015-12-31 | $0.02B | $0.00B | -11.11% |
| 2015-09-30 | $0.02B | $0.00B | -5.88% |
| 2015-06-30 | $0.02B | 0 | 0.00% |
| 2015-03-31 | $0.02B | $0.00B | 5.88% |
| 2014-12-31 | $0.02B | $0.00B | 10.53% |
| 2014-09-30 | $0.02B | $0.00B | 14.29% |
| 2014-06-30 | $0.02B | $0.00B | 14.29% |
| 2014-03-31 | $0.02B | $0.00B | 15.00% |
| 2013-12-31 | $0.02B | $0.00B | 15.00% |
| 2013-09-30 | $0.02B | $0.00B | 15.79% |
| 2013-06-30 | $0.02B | $0.00B | 10.53% |
| 2013-03-31 | $0.02B | $0.00B | 10.53% |
| 2012-12-31 | $0.02B | $0.00B | 11.11% |
| 2012-09-30 | $0.02B | $0.00B | 11.11% |
| 2012-06-30 | $0.02B | $0.00B | 12.50% |
| 2012-03-31 | $0.01B | $0.00B | 7.14% |
| 2011-12-31 | $0.01B | 0 | 0.00% |
| 2011-09-30 | $0.01B | $0.00B | 18.18% |
| 2011-06-30 | $0.01B | $0.00B | 40.00% |
| 2011-03-31 | $0.01B | $0.01B | 66.67% |
| 2010-12-31 | $0.01B | $0.01B | 100.00% |
| 2010-09-30 | $0.01B | $0.01B | 100.00% |
| 2010-06-30 | $0.01B | $0.01B | 100.00% |
| 2010-03-31 | $0.01B | $0.01B | 100.00% |
| 2009-12-31 | $0.01B | $0.01B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.127B | $0.064B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
| Boston Scientific (BSX) | United States | $151.510B | 37.93 |
| Stryker (SYK) | United States | $148.668B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
| Medtronic (MDT) | Ireland | $113.608B | 16.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.623B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
| Agilent Technologies (A) | United States | $34.375B | 22.41 |
| Terumo (TRUMY) | Japan | $24.785B | 32.19 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $20.867B | 81.91 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
| Baxter (BAX) | United States | $15.734B | 11.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.038B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.823B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
| Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
| Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
| Haemonetics (HAE) | United States | $3.650B | 16.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.415B | 28.38 |
| ICU Medical (ICUI) | United States | $3.262B | 24.05 |
| QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
| LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| Acuren (TIC) | United States | $1.379B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
| Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
| Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
| Neogen (NEOG) | United States | $1.137B | 14.56 |
| BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
| InMode (INMD) | Israel | $0.971B | 9.78 |
| Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Owens & Minor (OMI) | United States | $0.695B | 5.76 |
| Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Evolus (EOLS) | United States | $0.597B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| SNDL (SNDL) | Canada | $0.363B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Quanterix (QTRX) | United States | $0.327B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
| Cerus (CERS) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.268B | 12.19 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
| Brainsway (BWAY) | Israel | $0.243B | 64.35 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.47 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Jin Medical (ZJYL) | China | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.57 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |